NeuroMetrix Board Appointment and Equity Program Termination

Neurometrix (NURO) has shared an update.

NeuroMetrix, Inc. has announced the appointment of Joshua Horowitz to its Board of Directors, where he’ll serve until the 2025 annual meeting. Horowitz’s new role does not entail any related party transactions that would require reporting. He’ll be compensated with $60,000 in restricted stock units, vesting quarterly, and an $80,000 annual cash payment, alongside indemnification as per the company’s amended agreement. Additionally, NeuroMetrix terminated its existing equity offering program with Ladenburg Thalmann & Co. Inc., with the termination set to be effective within 10 days. These strategic moves, including Horowitz’s appointment, reflect the company’s evolving governance structure and financial strategy.

Learn more about NURO stock on TipRanks’ Stock Analysis page.